Skip to main content

Advertisement

SpringerLink
Log in

Long-term results of chemoradiotherapy with elective nodal irradiation for resectable locally advanced esophageal cancer in three-dimensional planning system

  • Original Article
  • Published:
International Journal of Clinical Oncology Aims and scope Submit manuscript

Abstract

Background

We evaluated the long-term results of definitive chemoradiotherapy (CRT) with elective nodal irradiation (ENI) using a three-dimensional (3D) planning system for resectable, locally advanced esophageal squamous cell carcinoma (LA-ESCC).

Methods

This retrospective study included 65 patients with LA-ESCC who started CRT between 2006 and 2017. Patients with Stage I–IV LA-ESCC according to the Union for International Cancer Control TNM classification (eighth edition) were included. In stage IV, only supraclavicular lymph node (LN) metastasis was included. All patients received radiotherapy with ENI and concurrent chemotherapy with platinum and 5-fluorouracil.

Results

The median age of the patients was 70 years (range 52–83 years). Stage I, II, III, and IV diseases were observed in 3 (5%), 28 (43%), 22 (34%), and 12 patients (18%), respectively. The median prescription dose was 66 Gy (range 50.4–66 Gy). The median follow-up period for the survivors was 71 months (range 8–175 months). The 5-year overall survival (OS) and progression-free survival rates were 54 and 43%, respectively. The 5-year OS rates for stages I–II and III–IV were 67 and 42%, respectively. Recurrence occurred in 29 patients (45%), and recurrence of regional LNs only occurred in 2 patients (3%). Grade 3 or higher late adverse events were observed in 8 patients (12%). Grade 5 heart failure occurred in two patients (3%); both had cardiovascular disease before treatment.

Conclusion

The long-term results of definitive CRT with ENI for resectable LA-ESCC were favorable. ENI with a 3D planning system may reduce regional LN recurrence and late adverse events.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Ando N, Iizuka T, Ide H et al (2003) Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: a Japan clinical oncology group study—JCOG9204. J Clin Oncol 21:4592–4596

    Article  PubMed  Google Scholar 

  2. Ando N, Kato H, Igaki H et al (2012) A randomized trial comparing postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus preoperative chemotherapy for localized advanced squamous cell carcinoma of the thoracic esophagus (JCOG9907). Ann Surg Oncol 19:68–74

    Article  PubMed  Google Scholar 

  3. Shapiro J, van Lanschot JJB, Hulshof MCCM et al (2015) Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial. Lancet Oncol 16:1090–1098

    Article  PubMed  Google Scholar 

  4. Cooper JS, Guo MD, Herskovic A et al (1999) Chemoradiotherapy of locally advanced Esophageal cancer long-term follow-up of a prospective randomized trial (RTOG 85–01). JAMA 281:1623–1627

    Article  CAS  PubMed  Google Scholar 

  5. Kato K, Muro K, Minashi K et al (2011) Phase II study of chemoradiotherapy with 5-fluorouracil and cisplatin for stage II–III esophageal squamous cell carcinoma: JCOG trial (JCOG 9906). Int J Radiat Oncol Biol Phys 81:684–690

    Article  CAS  PubMed  Google Scholar 

  6. Esophageal and Esophagogastric Junction Cancers, Version 4 (2021) NCCN Clinical Practice Guidelines in Oncology

  7. Kitagawa Y, Uno T, Oyama T et al (2019) Esophageal cancer practice guidelines 2017 edited by the Japan Esophageal Society: part 1. Esophagus 16:1–24

    Article  PubMed  Google Scholar 

  8. Ishida K, Ando N, Yamamoto S et al (2004) Phase II study of cisplatin and 5-fluorouracil with concurrent radiotherapy in advanced squamous cell carcinoma of the esophagus: a Japan Esophageal oncology group (JEOG)/Japan clinical oncology group trial (JCOG9516). Jpn J Clin Oncol 34:615–619

    Article  PubMed  Google Scholar 

  9. Onozawa M, Nihei K, Ishikura S et al (2009) Elective nodal irradiation (ENI) in definitive chemoradiotherapy (CRT) for squamous cell carcinoma of the thoracic esophagus. Radiother Oncol 92:266–269

    Article  CAS  PubMed  Google Scholar 

  10. Kato K, Nakajima TE, Ito Y et al (2013) Phase II study of concurrent chemoradiotherapy at the dose of 50.4 Gy with elective nodal irradiation for Stage II–III esophageal carcinoma. Jpn J Clin Oncol 43:608–615

    Article  PubMed  Google Scholar 

  11. Sun Y, Zhang XL, Mao QF et al (2018) Elective nodal irradiation or involved-field irradiation in definitive chemoradiotherapy for esophageal squamous cell cancer: a retrospective analysis in clinical N0 patients. Curr Oncol 25:e423–e429

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Cheng YJ, Jing SW, Zhu LL et al (2018) Comparison of elective nodal irradiation and involved-field irradiation in esophageal squamous cell carcinoma: a meta-analysis. J Radiat Res 59:604–615

    Article  PubMed  PubMed Central  Google Scholar 

  13. Li M, Zhang X, Zhao F et al (2016) Involved-field radiotherapy for esophageal squamous cell carcinoma: theory and practice. Radiat Oncol 11:18

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Watanabe M, Toh Y, Ishihara R et al (2022) Comprehensive registry of esophageal cancer in Japan, 2014. Esophagus 19:1–26

    Article  PubMed  Google Scholar 

  15. Kodama M, Kakegawa T (1998) Treatment of superficial cancer of the esophagus: a summary of responses to a questionnaire on superficial cancer of the esophagus in Japan. Surgery 123:432–439

    Article  CAS  PubMed  Google Scholar 

  16. Bollschweiler E, Baldus SE, Schröder W et al (2006) High rate of lymph-node metastasis in submucosal esophageal squamous-cell carcinomas and adenocarcinomas. Endoscopy 38:149–156

    Article  CAS  PubMed  Google Scholar 

  17. Akiyama H, Tsurumaru M, Udagawa H et al (1994) Radical lymph node dissection for cancer of the thoracic esophagus. Ann Surg 220:364–373

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Kato H, Watanabe H, Tachimori Y et al (1991) Evaluation of neck lymph node dissection for thoracic esophageal carcinoma. Ann Thorac Surg 51:931–935

    Article  CAS  PubMed  Google Scholar 

  19. Minsky BD, Pajak TF, Ginsberg RJ et al (2002) INT 0123 (radiation therapy oncology group 94–05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy. J Clin Oncol 20:1167–1174

    Article  CAS  PubMed  Google Scholar 

  20. Low DE, Kuppusamy MK, Alderson D et al (2019) Benchmarking complications associated with esophagectomy. Ann Surg 269:291–298

    Article  PubMed  Google Scholar 

  21. Lin SH, Wang L, Myles B et al (2012) Propensity score-based comparison of long-term outcomes with 3-dimensional conformal radiotherapy vs. intensity-modulated radiotherapy for esophageal cancer. Int J Radiat Oncol Biol Phys 84:1078–1085

    Article  PubMed  PubMed Central  Google Scholar 

  22. Lin SH, Zhang N, Godby J et al (2016) Radiation modality use and cardiopulmonary mortality risk in elderly patients with esophageal cancer. Cancer 122:917–928

    Article  PubMed  Google Scholar 

  23. Takeuchi Y, Murakami Y, Kameoka T et al (2020) Analysis of cardiac toxicity after definitive chemoradiotherapy for esophageal cancer using a biological dose-volume histogram. J Radiat Res 61:298–306

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Hulshof MCCM, Geijsen ED, Rozema T et al (2021) Randomized study on dose escalation in definitive chemoradiation for patients with locally advanced esophageal cancer (ARTDECO Study). J Clin Oncol 39:2816–2824

    Article  CAS  PubMed  Google Scholar 

  25. Crehange G, M’vondo C, Bertaut A et al (2021) Exclusive chemoradiotherapy with or without radiation dose escalation in esophageal cancer: multicenter phase 2/3 randomized trial CONCORDE (PRODIGE-26). Int J Radiat Oncol Biol Phys 111:S5

    Article  Google Scholar 

  26. Ito Y, Takeuchi H, Ogawa G et al (2020) Final analysis of single-arm confirmatory study of definitive chemoradiotherapy including salvage treatment in patients with clinical stage II/III esophageal carcinoma: JCOG0909. J Clin Oncol 38:4545

    Article  Google Scholar 

  27. Takada A, Nakamura T, Takayama K et al (2016) Preliminary treatment results of proton beam therapy with chemoradiotherapy for stage I–III esophageal cancer. Cancer Med 5:506–515

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Xi M, Xu C, Liao Z et al (2017) Comparative outcomes after definitive chemoradiotherapy using proton beam therapy versus intensity modulated radiation therapy for esophageal cancer: a retrospective, single-institutional analysis. Int J Radiat Oncol Biol Phys 99:667–676

    Article  PubMed  Google Scholar 

  29. Moslehi JJ (2016) Cardiovascular toxic effects of targeted cancer therapies. N Engl J Med 375:1457–1467

    Article  CAS  PubMed  Google Scholar 

  30. Armenian SH, Lacchetti C, Barac A et al (2017) Prevention and monitoring of cardiac dysfunction in survivors of adult cancers: american society of clinical oncology clinical practice guideline. J Clin Oncol 35:893–911

    Article  PubMed  Google Scholar 

  31. Kubota S, Hara H, Hiroi Y (2021) Current status and future perspectives of onco-cardiology: Importance of early detection and intervention for cardiotoxicity, and cardiovascular complication of novel cancer treatment. Glob Health Med 3:214–225

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiation Oncology, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551, Japan

    Shota Miyoshi, Ikuno Nishibuchi, Yuji Murakami, Tsuyoshi Katsuta, Nobuki Imano, Junichi Hirokawa & Yasushi Nagata

  2. Department of Surgical Oncology, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551, Japan

    Yoichi Hamai, Manabu Emi & Morihito Okada

Authors
  1. Shota Miyoshi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ikuno Nishibuchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yuji Murakami
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Tsuyoshi Katsuta
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Nobuki Imano
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Junichi Hirokawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Yoichi Hamai
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Manabu Emi
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Morihito Okada
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Yasushi Nagata
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ikuno Nishibuchi.

Ethics declarations

Conflict of interest

The authors have no conflicts of interest to declare.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Miyoshi, S., Nishibuchi, I., Murakami, Y. et al. Long-term results of chemoradiotherapy with elective nodal irradiation for resectable locally advanced esophageal cancer in three-dimensional planning system. Int J Clin Oncol 28, 382–391 (2023). https://doi.org/10.1007/s10147-023-02290-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10147-023-02290-5

Keywords

Search

Navigation